Saliva Test Improves Oropharyngeal Cancer Detection
Cancers in the back of the mouth and the upper throat often aren’t diagnosed until they reach their advanced stages because their location.
Industry News
Todays Dental News
How the ADA Oral Cancer Policy Amendment Will Affect Your Practice
The ADA recently announced an expansion to its policy on oral cancer detection recommending that dentists and dental hygienists perform routine examinations for oral.
Industry News
Head and Neck Cancer Risk Factors Identified Among 9/11 Responders
Researchers at the Rutgers School of Public Health have identified factors that may put people who responded to the 9/11 terrorist attacks at.
Todays Dental News
Saving a Life from Oral Cancer Only Takes Five Minutes
April is Oral Cancer Awareness Month, when our attention turns once again to a cancer that continues to increase each year. It’s true.
Industry News
HPV Infection Rates Rising Among Women
Human papillomavirus (HPV) infection rates are increasing in women born after 1980 who did not receive the HPV vaccine, putting them at higher.
Todays Dental News
Early Diagnosis of Oral Cancer Can Save Lives
This April is the twentieth annual Oral Cancer Awareness Month. The American Cancer Society estimates that roughly 53,000 people will get oral cavity.
Industry News
Webinar to Explore HPV’s Role in Oropharyngeal Cancer
Each year, the human papillomavirus (HPV) accounts for nearly 13,000 cases of oropharyngeal cancer, according to the Public Health Foundation (PHF). Yet awareness.
Industry News
ADA 2017 to Host Oropharyngeal Cancer Symposium
Oropharyngeal cancer continues to be diagnosed in 50,000 new patients each year, reports the American Cancer Society. To fight these numbers, the ADA.
Industry News
ADA 2017 to Host Oropharyngeal Cancer Symposium
Oropharyngeal cancer continues to be diagnosed in 50,000 new patients each year, reports the American Cancer Society. To fight these numbers, the ADA.
Industry News
MD Anderson and Hitachi to Collaborate on Head and Neck Cancer Therapy
The University of Texas MD Anderson Cancer Center and Hitachi Healthcare Americas will collaborate on a randomized clinical trial comparing the outcomes and.
